Ketamine: A Promising Novel Therapy for Anxiety and PTSD

  Article from Psychiatry Advisor: Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and...

New article: Ketamine may prevent suicidal ideation

MONDAY, Feb. 7, 2022 (HealthDay News) — A new clinical trial strengthens the case that ketamine — once famous as a club drug — can rapidly ease suicidal thoughts. Researchers found that among 156 adults hospitalized for severe suicidal thoughts,...

IV Ketamine Shows Promise in Clinical Trial with Depressed Teens

Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...

CNN Reports ‘Ketamine offers lifeline for suicidal thoughts’

CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials.  The segment featured Dr. Sanjay Gupta sharing the story of Alan Ferguson.  Mr....